Targeting SARS-CoV-2 infection through CAR-T like bispecific T cell engagers incorporating ACE2
M. Dogan, L. Kozhaya, L. Placek, F. Karabacak, M. Yigit, D. Unutmaz
This paper develops a bispecific T cell engager (ACE2-Bite) that targets SARS-CoV-2 infected cells and neutralizes variants, showing higher affinity for Delta and Omicron.
bioRxiv · Jan 19, 2022Bioengineering